New multiplexed flow cytometric assay to measure anti‐peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization

References

• van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recog-nized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643.
   PubMed Web of Science ®Google Scholar
• Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716.
   Google Scholar
• Bolland DJ, Hewitt JE. Intron loss in the SART1 genes of Fugu rubripes and Tetraodon nigrovir-idis. Gene 2001; 271: 43.
   PubMed Web of Science ®Google Scholar
• Hunziker IP, Zurbriggen R, Glueck R, Engler OB, Reichen J, Dai WJ, Pichler WJ, Cerny A. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Mol Immunol 2001; 38: 475.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MA, Kawakami Y, Seipp CA, Einhorn JH, White DE. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med 1998; 4: 321.
   PubMed Web of Science ®Google Scholar
• Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, van Wijck R, Lienard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jager E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, van der Bruggen P, Boon T. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A 1. Int. J Cancer 1999; 80: 219.
   PubMed Web of Science ®Google Scholar
• Jager E, Gnjatic S, Nagata Y, Stockert E, Jager D, Karbach J, Neumann A, Rieckenberg J, Chen YT, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A. Induction of primary NY-ESO-1 immunity: CD8 T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ES0-1+ cancers. Proc Natl Acad Sci USA 2000; 97: 12198.
   PubMed Web of Science ®Google Scholar
• Miyagi Y, Imai N, Sasatomi T, Yamada A, Mine T, Katagiri K, Nakagawa M, Muto A, Ohkouchi S, Isomoto H, Shirouzu K, Yamana H, Itoh K. Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination of SART3 peptides. Clin Cancer Res 2001; 7: 3950.
   Google Scholar
• Hida N, Maeda Y, Katagiri K, Takasu H, Harada M, Itoh K. A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation. Cancer Immunol Immunother 2002; 51: 219.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Hida N, Niiya F, Katagiri K, Harada M, Yamana H, Kamura T, Takahashi M, Sato Y, Todo S, Itoh K. Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients. Br J Cancer 2002; 87: 796.
   Google Scholar
• Komatsu N, Shichijo S, Maeda Y, Itoh K. Measurement of interferon-g by high-throughput fluorometric microvolume assay technology system. J Immunol Meth 2002; 263: 169.
   PubMed Web of Science ®Google Scholar
• Mine T, Sato Y, Noguchi M, Sasatomi T, Gouhara R, Tsuda N, Tanaka S, Shomura H, Katagiri K, Rikimaru T, Shichijo S, Kamura T, Hashimoto T, Shirouzu K, Yamada A, Todo S, Itoh K, Yamana H. Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing peptide-specific cellular responses. Clin Cancer Res 2004; 10: 929.
   PubMed Web of Science ®Google Scholar
• Vignali DAA. Multiplexed particle-based flow cytometric assays. J. Immunol Meth 2000; 243: 243.
   PubMed Web of Science ®Google Scholar
• Iannone MA, Taylor JD, Chen J, Li MS, Rivers P, Slentz-Kesler KA, Weiner MP. Multiplexed single nucleotide polymorphism genotyping by oligonu-cleotide ligation and flow cytometry. Cytometry 2000; 39: 131.
   Google Scholar
• Lobashevsky A, Senkbeil R, Townsend J, Shoaf J, McBride K, Sherard P, Wilson P, Burke R, Skelton S, Deierhoi M, Thomas J. HLA-A, B, DR loci molecular typing using fluorescence PCR-SSO luminex methodology. Hum Immunol 2002; 63: S91.
   Google Scholar
• de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diag-nostic Lab Immun 2003; 10: 133.
   PubMedGoogle Scholar
• Dunbar SA, Vander Zee CA, Oliver KG, Karem KL, Jacobson JW. Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAPTm system. J Microbio Meth 2003; 53: 245.
   PubMed Web of Science ®Google Scholar
• Mine T, Gouhara R, Hida N, Imai N, Azuma K, Rikimaru T, Katagiri K, Nishikori M, Sukehiro A, Nakagawa M, Yamada A, Aizawa H, Shirouzu K, Itoh K, Yamana H. Immunological elevation of CTL precursor-oriented vaccines for advanced lung cancer patients. Cancer Sci 2003; 94: 548.
   Google Scholar
• Noguchi M, Kobayashi K, Suetsugu N, Tomiyasu K, Suekane S, Yamada A, Itoh K, Noda S. Induction of cellular and humoral immune responses to tumor cells and peptide in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination. The Prostate 2003; 57: 80–92.
   PubMed Web of Science ®Google Scholar
• Ohkouchi S, Yamada A, Imai N, Mine T, Harada K, Shichijo S, Maeda Y, Saijo Y, Nukiwa T, Itoh K. Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals. Tissue Antigens 2002; 59: 259.
   PubMedGoogle Scholar
• Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K. Cellular and humoral immune responses to a human pancreatic cancer antigen coactosin-like protein, originally defined by the SEREX method. Eur J Immunol 2002; 32: 826.
   Google Scholar
• Kawamoto N, Yamada A, Ohkouchi S, Maeda T, Tanaka S, Hashimoto T, Saijo Y, Saijo S, Nukiwa T, Shichijo S, Aizawa H, Itoh K. IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients. Tissue Antigens 2003; 61: 352.
   PubMedGoogle Scholar